Report Detail
Global Anti-Neoplastic Pharmaceutical Agents Market Growth (Status and Outlook) 2019-2024
- RnM3396429 |
- 08 May, 2019 |
- Global |
- 116 Pages |
- LPI(LP Information) |
- Other
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
According to this study, over the next five years the Anti-Neoplastic Pharmaceutical Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Anti-Neoplastic Pharmaceutical Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Anti-Neoplastic Pharmaceutical Agents market by product type, application, key companies and key regions.
This study considers the Anti-Neoplastic Pharmaceutical Agents value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Hormones and Antagonists
Microorganism Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anti-Neoplastic Pharmaceutical Agents market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anti-Neoplastic Pharmaceutical Agents market by identifying its various subsegments.
Focuses on the key global Anti-Neoplastic Pharmaceutical Agents players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-Neoplastic Pharmaceutical Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Anti-Neoplastic Pharmaceutical Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Anti-Neoplastic Pharmaceutical Agents Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size 2014-2024
- 2.1.2 Anti-Neoplastic Pharmaceutical Agents Market Size CAGR by Region
- 2.2 Anti-Neoplastic Pharmaceutical Agents Segment by Type
- 2.2.1 Hormones and Antagonists
- 2.2.2 Microorganism Products
- 2.2.3 Plant Products
- 2.2.4 Antitumor Antibiotics
- 2.2.5 Alkylating Agents
- 2.2.6 Antimetabolites
- 2.2.7 Natural Products
- 2.3 Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 2.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (2014-2019)
- 2.4 Anti-Neoplastic Pharmaceutical Agents Segment by Application
- 2.4.1 Lung Cancer
- 2.4.2 Bladder Cancer
- 2.4.3 Breast Cancer
- 2.4.4 Cervical Cancer
- 2.4.5 Leukemia
- 2.4.6 Gynecological Cancer
- 2.4.7 Other
- 2.5 Anti-Neoplastic Pharmaceutical Agents Market Size by Application
- 2.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Application (2014-2019)
3 Global Anti-Neoplastic Pharmaceutical Agents by Players
- 3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Market Share by Players
- 3.1.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Players (2017-2019)
- 3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size Market Share by Players (2017-2019)
- 3.2 Global Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Anti-Neoplastic Pharmaceutical Agents by Regions
- 4.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions
- 4.2 Americas Anti-Neoplastic Pharmaceutical Agents Market Size Growth
- 4.3 APAC Anti-Neoplastic Pharmaceutical Agents Market Size Growth
- 4.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size Growth
- 4.5 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size Growth
5 Americas
- 5.1 Americas Anti-Neoplastic Pharmaceutical Agents Market Size by Countries
- 5.2 Americas Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 5.3 Americas Anti-Neoplastic Pharmaceutical Agents Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Anti-Neoplastic Pharmaceutical Agents Market Size by Countries
- 6.2 APAC Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 6.3 APAC Anti-Neoplastic Pharmaceutical Agents Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Anti-Neoplastic Pharmaceutical Agents by Countries
- 7.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents by Countries
- 8.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Type
- 8.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Anti-Neoplastic Pharmaceutical Agents Market Forecast
- 10.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Forecast (2019-2024)
- 10.2 Global Anti-Neoplastic Pharmaceutical Agents Forecast by Regions
- 10.2.1 Global Anti-Neoplastic Pharmaceutical Agents Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Anti-Neoplastic Pharmaceutical Agents Forecast by Type
- 10.8 Global Anti-Neoplastic Pharmaceutical Agents Forecast by Application
11 Key Players Analysis
- 11.1 GlaxoSmithKline plc.
- 11.1.1 Company Details
- 11.1.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 GlaxoSmithKline plc. News
- 11.2 F. Hoffmann-La Roche Ltd
- 11.2.1 Company Details
- 11.2.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 F. Hoffmann-La Roche Ltd News
- 11.3 Eli Lilly and Company
- 11.3.1 Company Details
- 11.3.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Eli Lilly and Company News
- 11.4 Bristol-Myers Squibb Company
- 11.4.1 Company Details
- 11.4.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Bristol-Myers Squibb Company News
- 11.5 Becton, Dickinson and Company
- 11.5.1 Company Details
- 11.5.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Becton, Dickinson and Company News
- 11.6 Pfizer Inc.
- 11.6.1 Company Details
- 11.6.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Pfizer Inc. News
- 11.7 Novartis AG
- 11.7.1 Company Details
- 11.7.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Novartis AG News
- 11.8 AstraZeneca
- 11.8.1 Company Details
- 11.8.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 AstraZeneca News
- 11.9 Gilead
- 11.9.1 Company Details
- 11.9.2 Anti-Neoplastic Pharmaceutical Agents Product Offered
- 11.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Gilead News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Anti-Neoplastic Pharmaceutical Agents . Industry analysis & Market Report on Anti-Neoplastic Pharmaceutical Agents is a syndicated market report, published as Global Anti-Neoplastic Pharmaceutical Agents Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Anti-Neoplastic Pharmaceutical Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
